The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
As of FY21, it is the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91 per cent share based on the value
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
The aim is to give a fillip to R&D in the health sector to face the Covid-19 challenge
The acquisition expands the company’s service portfolio in the transition care segment
Caspian Debt has in principle committed up to Rs 35 crores to SAMRIDH’s commercial debt investment pool
The company plans to invest in technology, business development, product innovation, and development across India
Subscribe To Our Newsletter & Stay Updated
